Literature DB >> 28722123

Value of Biomarkers in the Prevention of Rheumatoid Arthritis.

A Finckh1, D Alpizar-Rodriguez1, P Roux-Lombard2.   

Abstract

Recent diagnostic advances allow to identify persons in a pre-symptomatic stage of rheumatoid arthritis (RA), opening the way for a preventive therapeutic intervention, which may potentially be curative. We review and discuss existing biomarkers predictive of future onset of RA. A responsible use of biomarkers in clinical settings will require an integration of blood-based tests, imaging techniques, clinical history, environmental risk factors, and family history.
© 2017 American Society for Clinical Pharmacology and Therapeutics.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28722123     DOI： 10.1002/cpt.727

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


  5 in total

Review 1.  Interstitial Pneumonia with Autoimmune Features: What the Rheumatologist Needs to Know.

Authors:  Elena K Joerns; Traci N Adams; Jeffrey A Sparks; Chad A Newton; Bonnie Bermas; David Karp; Una E Makris
Journal:  Curr Rheumatol Rep       Date:  2022-06-01       Impact factor: 4.686

Review 2.  Potential clinical biomarkers in rheumatoid arthritis with an omic approach.

Authors:  Yolima Puentes-Osorio; Pedro Amariles; Miguel Ángel Calleja; Vicente Merino; Juan Camilo Díaz-Coronado; Daniel Taborda
Journal:  Auto Immun Highlights       Date:  2021-05-31

3.  Expression levels of IL-15 and IL-17 in synovial fluid of rheumatoid arthritis animal model.

Authors:  Yi Jin; Xiao Chen; Zongyan Gao; Ke Liu; Yi Hou; Jia Zheng
Journal:  Exp Ther Med       Date:  2018-08-22       Impact factor: 2.447

4.  Linc02381 Exacerbates Rheumatoid Arthritis Through Adsorbing miR-590-5p and Activating the Mitogen-Activated Protein Kinase Signaling Pathway in Rheumatoid arthritis-fibroblast-like synoviocytes.

Authors:  Jing Wang; Qing Zhao
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

Review 5.  Research progress of the application of mesenchymal stem cells in chronic inflammatory systemic diseases.

Authors:  Fangfang Huang; Erick Thokerunga; Fajian He; Xinyu Zhu; Zi Wang; Jiancheng Tu
Journal:  Stem Cell Res Ther       Date:  2022-01-08       Impact factor: 6.832
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.